Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration

被引:138
作者
Gradolatto, A
Basly, JP
Berges, R
Teyssier, C
Chagnon, MC
Siess, MH
Canivenc-Lavier, MC
机构
[1] INRA, Unite Mixte Rech Toxicol Alimentaire, F-21065 Dijon, France
[2] Lab Chim Analyt & Bromatol, Unite Format & Rech Pharm, Limoges, France
关键词
D O I
10.1124/dmd.104.000893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolism of apigenin, a weak estrogenic flavonoid phytochemical, was investigated in the rat. After a single oral administration of radiolabeled apigenin, 51.0% of radioactivity was recovered in urine, 12.0% in feces, 1.2% in the blood, 0.4% in the kidneys, 9.4% in the intestine, 1.2% in the liver, and 24.8% in the rest of the body within 10 days. Sex differences appear with regard to the nature of compounds eliminated via the urinary route: immature male and female rats, like mature female rats, excreted a higher percentage of the mono-glucuronoconjugate of apigenin than the mono-sulfoconjugate of apigenin (10.0-31.6% versus 2.0-3.6%, respectively). Mature male rats excreted the same compounds in an inverse ratio (4.9% and 13.9%, respectively). Radioactivity appeared in the blood only 24 h after oral administration. Blood kinetics showed a high elimination half-time (91.8 h), a distribution volume of 259 ml, and a plasmatic clearance of 1.95 ml/h. All of the parameters calculated from these experiments suggested a slow metabolism of apigenin, with a slow absorption and a slow elimination phase. Thus, a possible accumulation of this flavonoid in the body can be hypothesized.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 35 条
[1]   Bioavailability and metabolism of the flavonol quercetin in the pig [J].
Ader, P ;
Wessmann, A ;
Wolffram, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (07) :1056-1067
[2]   Identification of apigenin metabolites in rat liver perfusate by column switching high performance liquid chromatography/electrospray ionization mass spectrometry [J].
Basly, JP ;
Gradolatto, A ;
Teyssier, C ;
Canivenc-Lavier, NC .
MONATSHEFTE FUR CHEMIE, 2003, 134 (03) :355-359
[3]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[4]  
BOUTIN JA, 1993, DRUG METAB DISPOS, V21, P1157
[5]   Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability [J].
Breinholt, V ;
Hossaini, A ;
Svendsen, GW ;
Brouwer, C ;
Nielsen, SE .
FOOD AND CHEMICAL TOXICOLOGY, 2000, 38 (07) :555-564
[6]  
COVA D, 1992, INT J CLIN PHARM TH, V30, P29
[7]  
DAI R, 1997, LIFE SCI, V61, P75
[8]   Flavonoids: Old and new aspects of a class of natural therapeutic drugs [J].
Di Carlo, G ;
Mascolo, N ;
Izzo, AA ;
Capasso, F .
LIFE SCIENCES, 1999, 65 (04) :337-353
[9]   Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver [J].
Gradolatto, A ;
Canivenc-Lavier, MC ;
Basly, JP ;
Siess, MH ;
Teyssier, C .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) :58-65
[10]  
Graefe EU, 1999, INT J CLIN PHARM TH, V37, P219